NEW PUBLICATION – WHITE PAPER: Overcoming the barriers to treatment of rare cancer patients in the era of precision oncology: A call to action.
The Cancer Drug Development Forum (CDDF) is delighted to announce that the White Paper – “Overcoming the Barriers to Treatment of Rare Cancer”- has been published, following its “Innovation and Access in Rare Cancers” hybrid workshop held on 23-24 September 2024...
NEW PUBLICATION – WHITE PAPER: Dose Optimization in Cancer Drug Development – Review and Outcome of a Multi-Stakeholder Workshop
The Cancer Drug Development Forum (CDDF) is pleased to announce the release of a White Paper developed following the multi-stakeholder workshop “Dose Optimization in Cancer Drug Development,” held on 3–4 April 2023 in Amsterdam, the Netherlands, as a hybrid event....
Upcoming ACT EU Multi-Stakeholder Platform Advisory Group in June
Upcoming ACT EU Multi-Stakeholder Platform Advisory Group in June The Multi-stakeholder Platform Advisory Group (MSP Advisory Group) forms part of the ACT EU multi-stakeholder platform (ACT EU MSP), which aims to provide regulators and stakeholders with a...